CJC-1295 + Ipamorelin ou Tésamoréline

Recherche sur les hormones, l'hormone de croissance et la composition corporelle

The detail that decides this comparison is shelf life after reconstitution: tesamorelin has a working window of a few days, while a CJC-1295 blend holds for weeks refrigerated. That single handling property, more than any difference in mechanism, is why so much growth hormone research runs on CJC-1295 and ipamorelin instead.

They are closer relatives than people assume

Both tesamorelin and CJC-1295 are GHRH analogues. Both exist because natural growth hormone releasing hormone is destroyed within minutes by the enzyme DPP-4, and both solve that problem — just differently.

• Tesamorelin is GHRH(1-44) with a trans-3-hexenoyl group attached at the N-terminus. That added group is what shields it from DPP-4.
• CJC-1295 is the shorter GHRH(1-29) fragment carrying amino acid substitutions that achieve the same protection by a different route.

So the popular framing of “tesamorelin versus CJC” as two unrelated things is wrong. They are two engineering answers to one problem.

Where they genuinely differ

1. Shelf life once reconstituted

This is the practical gap, and it is a large one. Reconstituted tesamorelin is comparatively unstable: the usable window is generally counted in days — on the order of five — before the material can no longer be relied on. A reconstituted CJC-1295 blend, held refrigerated, is ordinarily good for weeks.

For a laboratory that difference is not academic. A vial with a five-day window forces the whole vial to be committed to a short block of work, and anything longitudinal either wastes material or means reconstituting again and again. A blend that keeps for weeks can simply be drawn from as the work proceeds.

Both are lyophilised powders in the vial, and in that dry state both keep for a long time when stored cold. The divergence appears only once they are in solution.

2. Duration in the body — and an honest correction

It is often claimed that CJC-1295 “lasts much longer” than tesamorelin. For the version most commonly sold, that is not true. Tesamorelin clears in roughly half an hour; CJC-1295 without DAC clears in roughly half an hour too. They are comparable.

The long-acting version is CJC-1295 with DAC, where albumin binding extends presence to something measured in days. That is a different compound, and if a vendor’s page does not state DAC status, the duration question cannot be answered at all. We cover that trap in our CJC-1295 buying guide.

3. One pathway or two

Tesamorelin is a GHRH analogue alone. The CJC-1295 + ipamorelin blend combines a GHRH analogue with a ghrelin receptor agonist — two distinct receptor systems rather than one. Most of the research interest in the blend comes from exactly that pairing, and it is something tesamorelin on its own cannot replicate.

4. Regulatory status and supply

Tesamorelin is unusual in this category: it exists as an approved prescription medicine in some markets under a brand name, for a specific clinical indication. That shapes its supply and its price. CJC-1295 and ipamorelin have no such approval anywhere and are supplied only as research materials. Neither route makes either compound appropriate for human use outside of medical care.

So which does research actually use?

For work that needs material held over a period rather than consumed in a single sitting, the CJC-1295 + ipamorelin blend is simply the more practical option — and it brings a second receptor pathway with it. Tesamorelin remains the more thoroughly characterised compound clinically, but its handling profile and its status as an approved medicine make it an awkward fit for most laboratory work.

Frequently asked questions

Is tesamorelin stronger than CJC-1295?

They are different GHRH analogues rather than different strengths of the same thing. Tesamorelin is the more clinically characterised; CJC-1295 without DAC has a broadly comparable duration, and the DAC version is far longer acting.

How long does tesamorelin last once reconstituted?

Its useful window in solution is short — commonly counted in days, on the order of five — after which the material can no longer be relied on. A reconstituted CJC-1295 blend held refrigerated typically remains usable for weeks.

Why is CJC-1295 sold with ipamorelin?

Because they act on separate receptors — GHRH and ghrelin — so the pair covers two pathways rather than one.

Does CJC-1295 last longer than tesamorelin?

Only the DAC version. Without DAC, the two are broadly comparable, which is why DAC status matters more than the brand name on the vial.

Sourcing note: for domestic-stock, purity and shipping details, see our Tesamorelin buying guide.

References

The published human CJC-1295 trial used the long-acting DAC analogue, not the no-DAC form. Ipamorelin has its own human pharmacokinetic study. No trial of the two combined was identified.

1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsTeichman SL et al. · J Clin Endocrinol Metab 2006 · PMID 16352683Randomised placebo-controlled trial in healthy adults — of the LONG-ACTING (DAC) CJC-1295 analogue, not the no-DAC form.
2. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteersGobburu JV et al. · Pharm Res 1999 · PMID 10496658Human pharmacokinetic/pharmacodynamic study; five escalating infusion levels, eight healthy male subjects per level.

Links open the study record on PubMed so the source can be checked directly. Listing a study is not a claim that its findings apply to any other use, product or route of administration. Research use only.